Metastatic gastric cancer

• A Phase I Interventional Open-Label, Non-Randomized Dose-Escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacody … Not authorised
  2024-516660-28-00 1 "Locally advanced, recurrent, or metastatic breast, gastric, "
• The IPa-Gastric trial: Comparing Intraperitoneal Paclitaxel and Systemic Therapy versus Systemic Therapy alone in Gastric Cancer Patients wi … Recruiting
  2024-514879-17-00 5 2025-11-05 "Gastric cancer"
• A Phase I Interventional Open-Label, Non-Randomized Dose-Escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacody … Recruiting
  2024-516660-28-01 1 2026-04-17 "Locally advanced, recurrent, or metastatic breast, gastric, "
• A study to investigate the safety and efficacy of ONA-255 in participants with advanced cancer Recruiting
  2025-522233-62-00 7 2025-12-12 "Advanced cancer; breast cancer; metastatic gastric / gastroe"
• A Randomized, Double-blinded, Multicenter, Phase Ⅲ Clinical Study of HLX22 (Recombinant Humanized Anti-HER2 Monoclonal Antibody Injection) i … Recruiting
  2024-516633-12-00 5 2025-06-30 "Locally advanced/ metastatic gastroesophageal junction and g"
• Trial of Trastuzumab Deruxtecan (Enhertu®) Plus Chemotherapy Plus or Minus Pembrolizumab versus Chemotherapy Plus Trastuzumab Plus or Minus … Recruiting
  2024-513122-27-00 5 2025-06-10 "Unresectable, Locally Advanced or Metastatic HER2 positive G"
• First -in-Human Study of DS-3939a in Subjects with Advanced Solid Tumors Recruiting
  2023-507937-14-00 7 2025-03-25 "Metastatic Solid Tumor"
• Watch-and-wait strategy to initiate Dostarlimab-based Immunotherapy in localized deficient mismatch repair (dMMR) and/or microsatellite inst … Recruiting
  2023-506102-39-00 4 2023-12-18 "metastatic gastric cancer"
• A Study of Zolbetuximab Together with Pembrolizumab and Chemotherapy in Adults with Gastric Cancer Recruitment ended
  2024-519773-19-00 5 2025-07-31 "Gastroesophageal Junction Adenocarcinoma"
• Phase 1b/2 Study of Anti-CEACAM5 ADC Precemtabart Tocentecan (M9140) in Participants With Advanced Gastric Cancer (Substudy GC) Recruitment ended
  2024-517817-34-00 9 2025-06-18 "Gastric Cancer"
• A Phase 1a/1b Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Malignancies Ended
  2023-504400-29-00 1 2022-09-15 "Advanced malignancies."
• A Phase 1a/1b Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BGB-5 … Ended
  2024-514704-13-00 1 "Advanced or Metastatic Solid Tumors with KRAS Mutations or A"

Showing 1–12 of 12 trials